Skip to main content

Table 2 Overall cure rate of MSC group versus non-MSC group

From: Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

  Cure case (%) Odd ratio (95% CI) p value
Severe pneumonia
 MSC (n = 16) 12 (75.0) 6.00 (1.26–28.5) 0.020
 Non-MSC (n = 15) 5 (33.3) Ref  
Non-severe pneumonia
 MSC (n = 31) 31 (100.0)
 Non-MSC (n = 45) 45 (100.0) Ref  
All cases
 MSC (n = 47) 43 (91.5) 2.15 (0.629–7.345) 0.214
 Non-MSC (n = 60) 50 (83.3) Ref